Antibodies to lymphotoxin alpha (LT alpha) and LT beta recognize different glial cell types in the central nervous system.
The cytokine lymphotoxin (LT) is known to exist in two forms, secreted LT alpha and a membrane-bound LT alpha/beta complex. LT alpha shares the same receptor as tumor necrosis factor alpha and LT beta is recognized by its receptor, LT betaR. Since LT has been associated with oligodendrocyte pathology, the present study has examined the expression of these molecules by immunocytochemistry in diseased and normal CNS tissue, with a panel of monoclonal antibodies (mAb) to LT alpha, LT beta and LT betaR. Of three mAb to LT beta, two (B27 and C37) gave specific membrane staining on astrocytes, as well as lymphocytes. The third anti-LT beta mAb, B9, was selectively immunoreactive for oligodendrocytes, suggesting specific recognition sites. The reactivity was not specific for multiple sclerosis (MS) since oligodendrocytes in normal and non-MS CNS tissue also displayed positivity. MAb to LT betaR reacted with astrocytes only, giving a punctate membrane staining pattern suggestive of receptor sites. MAb to LT alpha gave strong reactivity on lymphocytes in active MS lesions and weak reactivity on microglia within lesion areas. These results show that mAb to LT alpha and LT beta recognize different cell types within the CNS. Furthermore, individual mAb against LT beta were capable of distinguishing between astrocytes and oligodendrocytes, perhaps indicative of different epitopes on LT beta. The presence of LT betaR on astrocytes suggests possible interactions between infiltrating lymphocytes and astrocytes via the LT pathway.
Cannella
B
B
Department of Pathology, Rose F. Kennedy Center for Research in Mental Retardation and Human Development, Albert Einstein College of Medicine, Bronx, NY 10461, USA. cannella@aecom.yu.edu
Sizing
I D
ID
Benjamin
C D
CD
Browning
J L
JL
Raine
C S
CS
D000911:Antibodies, Monoclonal / Q000276:immunology*; D001253:Astrocytes / Q000276:immunology; D002490:Central Nervous System / Q000276:immunology* / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D008214:Lymphocytes / Q000276:immunology; D008233:Lymphotoxin-alpha / Q000276:immunology*; D053308:Lymphotoxin-beta; D008565:Membrane Proteins / Q000276:immunology*; D009103:Multiple Sclerosis / Q000276:immunology / Q000473:pathology; D009422:Nervous System Diseases / Q000276:immunology / Q000473:pathology; D009457:Neuroglia / Q000145:classification* / Q000276:immunology*; D009836:Oligodendroglia / Q000276:immunology; D012016:Reference Values
D000911:Antibodies, Monoclonal; C505886:LTB protein, human; D008233:Lymphotoxin-alpha; D053308:Lymphotoxin-beta; D008565:Membrane Proteins